Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 33% ± 13% | |
peripheral blood | 17 studies | 39% ± 13% | |
intestine | 11 studies | 34% ± 17% | |
brain | 10 studies | 31% ± 12% | |
kidney | 8 studies | 31% ± 12% | |
liver | 7 studies | 33% ± 21% | |
eye | 6 studies | 24% ± 8% | |
placenta | 5 studies | 30% ± 16% | |
bone marrow | 5 studies | 30% ± 10% | |
lymph node | 5 studies | 41% ± 11% | |
uterus | 4 studies | 38% ± 16% | |
breast | 4 studies | 29% ± 4% | |
adipose | 4 studies | 23% ± 8% | |
pancreas | 3 studies | 50% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 10588.41 | 459 / 459 | 100% | 328.21 | 1118 / 1118 |
esophagus | 100% | 8977.55 | 1445 / 1445 | 100% | 213.96 | 183 / 183 |
intestine | 100% | 9903.78 | 966 / 966 | 100% | 268.37 | 527 / 527 |
lung | 100% | 9407.94 | 578 / 578 | 100% | 226.50 | 1155 / 1155 |
ovary | 100% | 9105.09 | 180 / 180 | 100% | 238.12 | 430 / 430 |
pancreas | 100% | 9268.78 | 328 / 328 | 100% | 216.32 | 178 / 178 |
prostate | 100% | 7385.10 | 245 / 245 | 100% | 217.43 | 502 / 502 |
stomach | 100% | 7789.03 | 359 / 359 | 100% | 244.40 | 286 / 286 |
bladder | 100% | 9372.10 | 21 / 21 | 100% | 266.07 | 503 / 504 |
uterus | 100% | 8658.52 | 170 / 170 | 100% | 229.00 | 458 / 459 |
liver | 100% | 7745.67 | 226 / 226 | 100% | 158.05 | 405 / 406 |
thymus | 100% | 8301.18 | 653 / 653 | 100% | 199.16 | 602 / 605 |
brain | 99% | 5511.93 | 2623 / 2642 | 100% | 175.36 | 705 / 705 |
skin | 100% | 12245.03 | 1809 / 1809 | 99% | 199.71 | 467 / 472 |
kidney | 100% | 7801.66 | 89 / 89 | 98% | 189.51 | 879 / 901 |
adrenal gland | 100% | 10823.41 | 258 / 258 | 96% | 153.78 | 220 / 230 |
adipose | 100% | 11346.45 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9764.14 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 358.03 | 29 / 29 |
muscle | 100% | 6874.02 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 10838.30 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 212.65 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 87.48 | 1 / 1 |
peripheral blood | 98% | 9969.59 | 906 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 190.37 | 78 / 80 |
heart | 96% | 5189.72 | 825 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902018 | Biological process | negative regulation of cilium assembly |
GO_0007165 | Biological process | signal transduction |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0007264 | Biological process | small GTPase-mediated signal transduction |
GO_1903565 | Biological process | negative regulation of protein localization to cilium |
GO_0015031 | Biological process | protein transport |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0031982 | Cellular component | vesicle |
GO_0031267 | Molecular function | small GTPase binding |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0005093 | Molecular function | Rab GDP-dissociation inhibitor activity |
Gene name | GDI2 |
Protein name | Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2) Rab GDP dissociation inhibitor |
Synonyms | HEL-S-46e hCG_24071 RABGDIB |
Description | FUNCTION: GDP-dissociation inhibitor preventing the GDP to GTP exchange of most Rab proteins. By keeping these small GTPases in their inactive GDP-bound form regulates intracellular membrane trafficking . Negatively regulates protein transport to the cilium and ciliogenesis through the inhibition of RAB8A . . FUNCTION: Regulates the GDP/GTP exchange reaction of most RAB proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP. . FUNCTION: Regulates the GDP/GTP exchange reaction of most RAB proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP. . FUNCTION: Regulates the GDP/GTP exchange reaction of most RAB proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP. . FUNCTION: Regulates the GDP/GTP exchange reaction of most RAB proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP. . FUNCTION: Regulates the GDP/GTP exchange reaction of most RAB proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP. . FUNCTION: Regulates the GDP/GTP exchange reaction of most RAB proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP. . FUNCTION: Regulates the GDP/GTP exchange reaction of most RAB proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP. . |
Accessions | P50395 ENST00000447751.5 Q5SX91 ENST00000608581.5 Q5SX87 Q5SX90 ENST00000380127.5 ENST00000609712.1 Q5SX86 V9GYJ7 ENST00000418688.5 ENST00000456041.5 ENST00000380191.9 [P50395-1] ENST00000380181.7 [P50395-2] Q6IAT1 V9GYF8 |